Nieva, Shiela May .
HRN: 21-52-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2022
CEFUROXIME 500MG (TAB)
07/08/2022
07/15/2022
ORAL
500
BID
NSVD/ In Transit Delivery
Waiting Final Action
Indication: Prophylaxis Type of Infection: Febrile NeutropeniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes